Herpes‐like skin lesion after AstraZeneca vaccination for COVID‐19: A case report
Abstract Recurrent herpes simplex virus or varicella zoster virus infection should be considered as one of the rare complications after AstraZeneca vaccination for COVID‐19.
Main Authors: | Mohammadreza Ardalan, Hamidreza Moslemi, Shervin Shafiei, Reza Tabrizi, Mohammadreza Moselmi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-10-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.4883 |
Similar Items
-
Possibility of the blood clot, thrombotic thrombocytopenia following injection of COVID-19-vaccine AstraZeneca; a systematic review
by: Mahnaz Momenzadeh, et al.
Published: (2023-10-01) -
A case of Thrombotic Thrombocytopenic Purpura following the AstraZeneca Vaccine
by: Effat Iranijam, et al.
Published: (2022-12-01) -
Cerebral venous sinus thrombosis following intracerebral hemorrhage after COVID‐19 AstraZeneca vaccination: A case report
by: Arsh Haj Mohamad Ebrahim Ketabforoush, et al.
Published: (2022-11-01) -
Impact of Improper Storage of ChAdOx1-S (AstraZeneca) Vaccine on Its Efficacy and Safety
by: Marek Mikołajczyk, et al.
Published: (2022-12-01) -
A case of pityriasis rubra pilaris following AstraZeneca COVID-19 vaccine
by: Miki Wada, BMedSc, MD, et al.
Published: (2022-06-01)